Skip to main content

Table 3 Multivariate Analysis of Dose-volume Variables Associated with Pericardial Effusion

From: Pericardial effusion after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal cancer

Parameters

Pericardial effusion of any grade

Pericardial effusion ≥ Grade 3

P value

HR (95% CI)

P value

HR (95% CI)

Heart

 Mean (Gy)

< 0.001

9.792 (2.930–32.724)

NA

NA

 V5 (%)

0.001

6.670 (2.172–20.481)

NA

NA

 V10 (%)

0.001

7.292 (2.370–22.439)

NA

NA

 V20 (%)

< 0.001

10.681 (2.844–40.111)

NA

NA

 V30 (%)

< 0.001

10.813 (2.897–40.360)

NA

NA

 V40 (%)

< 0.001

7.191 (2.487–20.796)

NA

NA

 V50 (%)

0.002

4.977 (1.790–13.842)

NA

NA

 V60 (%)

0.363

1.407 (0.674–2.937)

0.055

5.495 (0.967–31.234)

Pericardium

 Mean (Gy)

< 0.001

9.597 (2.850–32.310)

NA

NA

 V5 (%)

0.001

6.408 (2.194–18.713)

NA

NA

 V10 (%)

0.001

8.507 (2.271–31.863)

NA

NA

 V20 (%)

< 0.001

10.324 (2.780–38.343)

NA

NA

 V30 (%)

0.001

8.269 (2.503–27.319)

0.010

32.309 (2.311–451.777)

 V40 (%)

< 0.001

7.064 (2.430–20.540)

0.005

16.715 (2.307–121.093)

 V50 (%)

0.001

5.312 (1.977–14.274)

NA

NA

 V60 (%)

0.349

1.406 (0.689–2.868)

0.025

7.545 (1.293–44.011)

  1. Variables taken into account in multivariate analysis included gender, tumor location, use of alcohol, cardiovascular disease and one of dose-volume parameters
  2. Abbreviations: Gy gray, NA not applicable, Vx percentage of the heart or pericardium volume receiving more than x gray